Bourla expects no changes to MFN deals after midterms
Pfizer CEO Albert Bourla said he doesn't expect likely Democratic gains in Congress to affect the pricing deals made between drug companies and the Trump White House. “I don't think that many things can move ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.